Cargando…

Effectiveness of rituximab in nephrotic syndrome treatment

Idiopathic nephrotic syndrome (INS) is a common chronic illness characterized by massive proteinuria and hypo-albuminemia in children. Baseline treatment is 6 month-corticotherapy. In cases of steroid resistant/dependent INS several types of treatment are used, including course of methyloprednisolon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Popko, Katarzyna, Górska, Elżbieta, Kuźma-Mroczkowska, Elżbieta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Polish Society of Experimental and Clinical Immunology 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708214/ https://www.ncbi.nlm.nih.gov/pubmed/29204098 http://dx.doi.org/10.5114/ceji.2017.70976

Ejemplares similares

Tuberculosis infection in children with proteinuria/nephrotic syndrome
por: Szymanik-Grzelak, Hanna, et al.
Publicado: (2017)

Acute tubulointerstitial nephritis following aciclovir treatment for chickenpox in children with nephrotic syndrome – a report of two cases
por: Pańczyk-Tomaszewska, Małgorzata, et al.
Publicado: (2021)

Levamisole therapy in children with frequently relapsing and steroid-dependent nephrotic syndrome: a single-center experience
por: Kuźma-Mroczkowska, Elżbieta, et al.
Publicado: (2016)

The role of natural killer cells in pathogenesis of autoimmune diseases
por: Popko, Katarzyna, et al.
Publicado: (2016)

Late-Onset Neutropenia after Rituximab Treatment for Adult-Onset Nephrotic Syndrome
por: Yamazaki, Mayuko, et al.
Publicado: (2019)

Rituximab Treatment for Nephrotic Syndrome in Children
por: Iijima, Kazumoto, et al.
Publicado: (2014)

Hypokalemia after rituximab administration in nephrotic syndrome: two case reports
por: Song, Yiyun, et al.
Publicado: (2023)

Rituximab for nephrotic syndrome in children
por: Iijima, Kazumoto, et al.
Publicado: (2016)

Necrotizing Fasciitis: A Side Effect of Rituximab Administration in Steroid-Dependent Nephrotic Syndrome
por: Safdar, Osama Yousif, et al.
Publicado: (2022)

Kinetics of Rituximab Excretion into Urine and Peritoneal Fluid in Two Patients with Nephrotic Syndrome
por: Stahl, Klaus, et al.
Publicado: (2017)

Mycoplasma pneumoniae as a trigger for Henoch-Schönlein purpura in children
por: Kuźma-Mroczkowska, Elżbieta, et al.
Publicado: (2016)

Long-term Successful Treatment of Rituximab for Steroid-resistant Minimal Change Nephrotic Syndrome and Idiopathic Thrombocytopenic Purpura
por: Nishikawa, Mana, et al.
Publicado: (2019)

Disseminated Intravascular Coagulation-like Reaction after Rituximab Infusion in a Patient with Nephrotic Syndrome
por: Nishiwaki, Hiroki, et al.
Publicado: (2019)

Rituximab Use in the Management of Childhood Nephrotic Syndrome
por: Kallash, Mahmoud, et al.
Publicado: (2019)

Asymmetric dimethylarginine is not a marker of arterial damage in children with glomerular kidney diseases
por: SKRZYPCZYK, PIOTR, et al.
Publicado: (2020)

Pharmacokinetics of rituximab in a pediatric patient with therapy-resistant nephrotic syndrome
por: Counsilman, Clare E., et al.
Publicado: (2015)

A prospective cohort study of rituximab in the treatment of refractory nephrotic syndrome
por: Xu, Jing, et al.
Publicado: (2021)

Mutational analysis in podocin-associated hereditary nephrotic syndrome in Polish patients: founder effect in the Kashubian population
por: Lipska, Beata S., et al.
Publicado: (2013)

Rituximab therapy in adults with steroid-dependent nephrotic syndrome
por: Zhong, Hongzhen, et al.
Publicado: (2019)

Successful Pregnancies in a Patient with Childhood-onset Steroid-dependent Nephrotic Syndrome during Rituximab Maintenance Therapy
por: Nara, Mizuho, et al.
Publicado: (2021)

Long-term repeated rituximab treatment for childhood steroid-dependent nephrotic syndrome
por: Kim, Ji Hyun, et al.
Publicado: (2017)

Rituximab treatment for refractory nephrotic syndrome in adults: a multicenter retrospective study
por: Ma, Xiaoyan, et al.
Publicado: (2023)

Acute acalculous cholecystitis in a 17-year-old girl with Epstein-Barr virus infection
por: Pawłowska-Kamieniak, Agnieszka, et al.
Publicado: (2015)

Rituximab in idiopathic nephrotic syndrome: still waiting for stronger evidences
por: Belangero, Vera Maria Santoro
Publicado: (2023)

Cost-Effectiveness of Administering Rituximab for Steroid-Dependent Nephrotic Syndrome and Frequently Relapsing Nephrotic Syndrome: A Preliminary Study in Japan
por: Takura, Tomoyuki, et al.
Publicado: (2017)

Circulating Anti-Rituximab Antibodies Do Not Affect Response to Rituximab in Steroid-Dependent Nephrotic Syndrome
por: Angeletti, Andrea, et al.
Publicado: (2022)

Rituximab treatment for difficult-to-treat nephrotic syndrome in children:a multicenter, retrospective study
por: TAŞDEMİR, Mehmet, et al.
Publicado: (2021)

Recurrent respiratory tract infections in children – analysis of immunological examinations
por: Raniszewska, Agata, et al.
Publicado: (2015)

Persistent SARS-CoV-2 Infection in a Patient with Nephrotic Syndrome under Rituximab Therapy: Successful Treatment with a Combination of Remdesivir and Monoclonal Antibodies
por: Shimizu, Akihiro, et al.
Publicado: (2022)

Efficacy of Semiannual Single Fixed Low-Dose Rituximab Therapy in Steroid-Dependent Minimal Change Nephrotic Syndrome: A Case Series
por: Usui, Ryosuke, et al.
Publicado: (2018)

Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials
por: Iijima, Kazumoto, et al.
Publicado: (2017)

Rituximab is not a “magic drug” in post-transplant recurrence of nephrotic syndrome
por: Grenda, Ryszard, et al.
Publicado: (2016)

The efficacy and safety of rituximab in treating childhood nephrotic syndrome: an Italian perspective
por: Maratea, Dario, et al.
Publicado: (2016)

Lupus nephritis in children – 10 years’ experience
por: Szymanik-Grzelak, Hanna, et al.
Publicado: (2016)

Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel
por: Bomback, Andrew S, et al.
Publicado: (2011)

Nephrotic Syndrome Induced by Lenvatinib Treatment for Hepatocellular Carcinoma
por: Prasoppokakorn, Thaninee, et al.
Publicado: (2022)

Low-dose rituximab is no less effective for nephrotic syndrome measured by 12-month outcome
por: Maxted, Andrew P., et al.
Publicado: (2018)

Rituximab for Children With Difficult-to-Treat Nephrotic Syndrome: Its Effects on Disease Progression and Growth
por: Topaloğlu, Rezan, et al.
Publicado: (2019)

Nephrotic syndrome associated with meningioma
por: Zachariah, P. P., et al.
Publicado: (2013)

An unusual case of nephrotic syndrome
por: Sahay, M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_r3js1ul7kkkk5l8sbi605td04t